Bangalore, Sripal

Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis

Bangalore, S., Kamalakkannan, G., Parkar, S., & Messerli, F. H. (2007) · The American Journal of Medicine

Medication Adherence and ComplianceBlood Pressure and Hypertension Studies

Cited by 1,075

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Azizi, M., Schmieder, R. E., Mahfoud, F., Weber, M. A., Daemen, J., Davies, J., Basile, J., Kirtane, A. J., Wang, Y., Lobo, M. D., et al. (2018) · The Lancet

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 740

Diabetes and hypertension: a position statement by the American Diabetes Association

de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S., & Bakris, G. (2017) · Diabetes Care

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 714

Obesity paradox in patients with hypertension and coronary artery disease

Uretsky, S., Messerli, F. H., Bangalore, S., Champion, A., Cooper-DeHoff, R. M., Zhou, Q., & Pepine, C. J. (2007) · The American Journal of Medicine

Blood Pressure and Hypertension StudiesCardiovascular Function and Risk Factors

Cited by 550

Management of coronary disease in patients with advanced kidney disease

Bangalore, S., Maron, D. J., O’Brien, S. M., Fleg, J. L., Kretov, E. I., Briguori, C., Kaul, U., Reynolds, H. R., Mazurek, T., Sidhu, M. S., et al. (2020) · New England Journal of Medicine

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 499

Atrial fibrillation and obesity—results of a meta-analysis

Wanahita, N., Messerli, F. H., Bangalore, S., Gami, A. S., Somers, V. K., & Steinberg, J. S. (2008) · American Heart Journal

Atrial Fibrillation Management and OutcomesCardiovascular Function and Risk Factors

Cited by 474

Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials

Bangalore, S., Kumar, S., Lobach, I., & Messerli, F. H. (2011) · Circulation

Blood Pressure and Hypertension StudiesDiabetes Treatment and Management

Cited by 437

β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

Bangalore, S., Steg, G., Deedwania, P., Crowley, K., Eagle, K. A., Goto, S., Ohman, E. M., Cannon, C. P., Smith, S. C., Zeymer, U., et al. (2012) · JAMA

Acute Myocardial Infarction ResearchCardiac Health and Mental Health

Cited by 436

Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials

Bangalore, S., Makani, H., Radford, M., Thakur, K., Toklu, B., Katz, S. D., DiNicolantonio, J. J., Devereaux, P. J., Alexander, K. P., Wetterslev, J., et al. (2014) · The American Journal of Medicine

Acute Myocardial Infarction ResearchCardiac Ischemia and Reperfusion

Cited by 315

A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus

Bangalore, S., Parkar, S., Grossman, E., & Messerli, F. H. (2007) · The American Journal of Cardiology

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 290

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials

Makani, H., Bangalore, S., Desouza, K. A., Shah, A., & Messerli, F. H. (2013) · BMJ

Renin-Angiotensin System StudiesHeart Failure Treatment and Management

Cited by 244

Cardiovascular Protection Using Beta-Blockers

Bangalore, S., Messerli, F. H., Kostis, J. B., & Pepine, C. J. (2007) · Journal of the American College of Cardiology

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 233

Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal Disease: Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Muntner, P., Davis, B. R., Cushman, W. C., Bangalore, S., Calhoun, D. A., Pressel, S. L., Black, H. R., Kostis, J. B., Probstfield, J. L., Whelton, P. K., et al. (2014) · Hypertension

Blood Pressure and Hypertension StudiesHormonal Regulation and Hypertension

Cited by 231

Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials

Bangalore, S., Fakheri, R., Toklu, B., & Messerli, F. H. (2016) · BMJ

Blood Pressure and Hypertension StudiesRenin-Angiotensin System Studies

Cited by 183

Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering Syndrome

Messerli, F. H., Bangalore, S., Makani, H., Rimoldi, S. F., Allemann, Y., White, C. J., Textor, S., & Sleight, P. (2011) · European Heart Journal

Renal and Vascular PathologiesRenin-Angiotensin System Studies

Cited by 183

Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors

Makani, H., Messerli, F. H., Romero, J., Wever-Pinzon, O., Korniyenko, A., Berrios, R. S., & Bangalore, S. (2012) · The American Journal of Cardiology

Coagulation, Bradykinin, Polyphosphates, and AngioedemaRenin-Angiotensin System Studies

Cited by 175

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease

Bangalore, S., Fayyad, R., Laskey, R., DeMicco, D. A., Deedwania, P., Kostis, J. B., & Messerli, F. H. (2014) · The American Journal of Medicine

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 93

Evidence-based practices in the cardiac catheterization laboratory: a scientific statement from the American Heart Association

Bangalore, S., Barsness, G. W., Dangas, G. D., Kern, M. J., Rao, S. V., Shore-Lesserson, L., Tamis-Holland, J. E., & on behalf of the American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. C. O. C. S. A. A. A. C. O. L. A. C. H. (2021) · Circulation

Coronary Interventions and DiagnosticsVascular Procedures and Complications

Cited by 92

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome

Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC

Diabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes

Cited by 90

Health status after invasive or conservative care in coronary and advanced kidney disease

Spertus, J. A., Jones, P. G., Maron, D. J., Mark, D. B., O’Brien, S. M., Fleg, J. L., Reynolds, H. R., Stone, G. W., Sidhu, M. S., Chaitman, B. R., et al. (2020) · New England Journal of Medicine

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 84

2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?

Bangalore, S., Fayyad, R., Kastelein, J. J., Laskey, R., Amarenco, P., DeMicco, D. A., & Waters, D. D. (2016) · The American Journal of Medicine

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 51

The Blood Pressure Landscape

Messerli, F. H., & Bangalore, S. (2018) · Journal of the American College of Cardiology

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 25